Skip to main content

Table 2 Multivariate cox regression analyses demonstrating association of WHR, PLR, LMR and NLR with overall survival

From: Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients

 

Variable

Hazard Ratio (95% CI)

p value

Model 1a

WHR category (≥2.855 vs. < 2.855)

8.14 (5.14–12.89)

< 0.001

Model 2b

PLR category (≥133.03 vs. < 133.03)

1.38 (1.08–1.75)

0.009

Model 3c

LMR category (≥3.405 vs. < 3.405)

0.62 (0.49–0.78)

< 0.001

Model 4d

NLR category (≥2.61 vs. < 2.61)

1.33 (1.05–1.68)

0.018

Model 5e

WHR category (≥2.855 vs. < 2.855)

1.58 (1.2–2.06)

0.001

PLR category (≥133.03 vs. < 133.03)

1.1 (0.85–1.43)

0.477

LMR category (≥3.405 vs. < 3.405)

0.71 (0.55–0.94)

0.014

NLR category (≥2.61 vs. < 2.61)

1.03 (0.79–1.36)

0.817

  1. aAdjusted for WHR, age, sex, ASA, adjuvant chemotherapy, comorbidity, complication, tumor size, vascular invasion, and cancer stage
  2. bAdjusted for PLR, age, sex, ASA, adjuvant chemotherapy, comorbidity, complication, tumor size, vascular invasion, and cancer stage
  3. cAdjusted for LMR, age, sex, ASA, adjuvant chemotherapy, comorbidity, complication, tumor size, vascular invasion, and cancer stage
  4. dAdjusted for NLR, age, sex, ASA, adjuvant chemotherapy, comorbidity, complication, tumor size, vascular invasion, and cancer stage
  5. eAdjusted for WHR, PLR, LMR, NLR, age, sex, ASA, adjuvant chemotherapy, comorbidity, complication, tumor size, vascular invasion, and cancer stage